Spots Global Cancer Trial Database for leustatin
Every month we try and update this database with for leustatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) | NCT01515527 | Leukemia | Cladribine Cytarabine Decitabine | 60 Years - | M.D. Anderson Cancer Center | |
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab | NCT00667329 | Lymphoma | 2CdA Cyclophosphamid... Rituximab | - | M.D. Anderson Cancer Center | |
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab | NCT00667329 | Lymphoma | 2CdA Cyclophosphamid... Rituximab | - | M.D. Anderson Cancer Center |